SCHEMBL950400

SCHEMBL950400

CC(=O)Nc1ccc2cc(S(=O)(=O)O)ccc2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SNCA P37840 2/20 0.59
CASP6 P55212 1/20 0.57
CA2 P00918 4/20 0.54
CA1 P00915 3/20 0.54
CA12 O43570 2/20 0.54
CA9 Q16790 2/20 0.54
MMP1 P03956 1/20 0.53
MMP2 P08253 1/20 0.53
MMP9 P14780 1/20 0.53
MMP8 P22894 1/20 0.53
MMP13 P45452 1/20 0.53
KDM4E B2RXH2 1/20 0.53
MEN1 O00255 1/20 0.53
NPC1 O15118 1/20 0.53
GLA P06280 1/20 0.53
MAPT P10636 1/20 0.53
TNNI3 P19429 1/20 0.53
TNNT2 P45379 1/20 0.53
RAB9A P51151 1/20 0.53
TNNC1 P63316 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8784484 0.98 SNCA (0.58) SNCACASP6CA2CA1CA12
Water SCHEMBL11035834 0.98 SNCA (0.58) SNCACASP6CA2CA1CA12
SCHEMBL6079123 0.95 CASP6 (0.56) SNCACASP6CA2CA1CA12
SCHEMBL6079107 0.93 CASP6 (0.55) SNCACASP6CA2CA1CA12
Pyridine SCHEMBL950273 0.89 SNCA (0.54) SNCACASP6CA2CA1CA12
SCHEMBL10388565 0.85 CYP2C19 (0.48) SNCACASP6CA2CA1CA12
SCHEMBL8577441 0.85 MEN1 (0.68) CA2CA1CA12CA9KDM4E
SCHEMBL949134 0.85 CA2 (0.53) CA2CA1CA12CA9MMP1
SCHEMBL8784476 0.85 CA2 (0.53) CA2CA1CA12CA9MMP1
SCHEMBL1803097 0.85 NT5E (0.75) SNCACASP6CA2CA1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4908478-A Single-vessel process for preparing 2-acetaminonaphthalene-6-sulfonic acid of high purity HOECHST AKTIENGESELLSCHAFT (DE) 1990-03-13 US claimed
EP-0218005-B1 SINGLE POT PROCESS FOR THE PRODUCTION OF 2-ACETAMIDONAPHTHALENE-6-SULPHONIC ACID WITH A HIGH PURITY HOECHST AKTIENGESELLSCHAFT (DE) 1988-11-23 EP claimed
US-8419849-B2 Disazo dyes and their use in ink-jet printing FUJIFILM IMAGING COLORANTS LIMITED (GB) 2013-04-16 US disclosed
EP-2344589-B1 DISAZO COMPOUNDS AND THEIR USE IN INK-JET PRINTING FUJIFILM IMAGING COLORANTS LTD (GB) 2013-01-16 EP disclosed
US-20110195236-A1 Disazo Dyes And Their Use in Ink-Jet Printing FUJIFILM CORPORATION (JP) 2011-08-11 US disclosed
US-20110009389-A1 IMIDAZOLE DERIVATIVE, THEIR PRODUCTION AND USE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
WO-2010041066-A2 DISAZO COMPOUNDS AND THEIR USE IN INK-JET PRINTING FUJIFILM IMAGING COLORANTS LIMITED (GB) 2010-04-15 WO disclosed
US-20070004736-A1 Imidazole derivative, process for producing the same, and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-01-04 US disclosed
EP-1564213-A1 IMIDAZOLE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE Takeda Pharmaceutical Company Limited (JP) 2005-08-17 EP disclosed
US-4960870-A DYEING WOOL, POLYAMIDES; FIBER REACTIVE DYES CIBA-GEIGY CORPORATION (US) 1990-10-02 US disclosed
US-4908478-A Single-vessel process for preparing 2-acetaminonaphthalene-6-sulfonic acid of high purity HOECHST AKTIENGESELLSCHAFT (DE) 1990-03-13 US disclosed
EP-0210492-B1 WATER-SOLUBLE MONOAZO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS DYESTUFFS HOECHST CELANESE CORPORATION (US) 1989-03-08 EP disclosed
EP-0218005-B1 SINGLE POT PROCESS FOR THE PRODUCTION OF 2-ACETAMIDONAPHTHALENE-6-SULPHONIC ACID WITH A HIGH PURITY HOECHST AKTIENGESELLSCHAFT (DE) 1988-11-23 EP disclosed
EP-0218005-B1 SINGLE POT PROCESS FOR THE PRODUCTION OF 2-ACETAMIDONAPHTHALENE-6-SULPHONIC ACID WITH A HIGH PURITY HOECHST AKTIENGESELLSCHAFT (DE) 1988-11-23 EP disclosed
US-4749523-A NEUTRALIZING ACID AND SUBSEQUENT AMINE ACYLATION TO AMIDE GROUP; EFFICIENT HOECHST CELANESE CORPORATION (US) 1988-06-07 US disclosed
EP-0168680-B1 SOLID PHASE ACYLATION OF AMINOSULFONIC ACIDS HOECHST CELANESE CORPORATION (US) 1988-03-09 EP disclosed
EP-0218005-A1 Single pot process for the production of 2-acetamidonaphthalene-6-sulphonic acid with a high purity HOECHST AKTIENGESELLSCHAFT (DE) 1987-04-15 EP disclosed
EP-0218005-A1 Single pot process for the production of 2-acetamidonaphthalene-6-sulphonic acid with a high purity HOECHST AKTIENGESELLSCHAFT (DE) 1987-04-15 EP disclosed
EP-0168680-A1 Solid phase acylation of aminosulfonic acids HOECHST CELANESE CORPORATION (US) 1986-01-22 EP disclosed
US-4487725-A Process for the preparation of N-acetylaminoarylsulfonic acids in sulfuric acid as solvent HOECHST AKTIENGESELLSCHAFT (DE) 1984-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070004736-A1 Imidazole derivative, process for producing the same, and use HRH4, F2, HRH2 SNCA 3053/4885CASP6 3275/4885CA2 2796/4885
US-20110009389-A1 IMIDAZOLE DERIVATIVE, THEIR PRODUCTION AND USE F2, H1-3, CYC1 SNCA 3232/4885CASP6 3326/4885CA2 3237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.